| abstract |
The present disclosure relates to fused imidazole compounds, their preparation methods and their medical applications. Specifically, the present disclosure relates to a fused imidazole compound represented by the general formula (I), a preparation method thereof, a pharmaceutical composition containing the compound, and its use as a therapeutic agent, especially as a GLP-1 receptor Use of a somatic agonist and in the manufacture of a medicament for the treatment and/or prevention of diabetes. |